Please use this identifier to cite or link to this item: http://hdl.handle.net/10419/234806
Authors: 
Fonseca, Raquel
Langot, François
Michaud, Pierre-Carl
Sopraseuth, Thepthida
Year of Publication: 
2020
Series/Report no.: 
Document de travail No. 2020-06
Publisher: 
Université du Québec à Montréal, École des sciences de la gestion (ESG UQAM), Département des sciences économiques, Montréal
Abstract: 
Using a general equilibrium heterogeneous agent model featuring health production, we quantify the relative contribution of price distortions in the health market, TFP and other health risks in explaining cross-country differences in health expenditure (as a share of GDP) and health status. Estimated parameters reveal a substantial price wedge that explains at most 20% of the difference in health spending (as a share of GDP) and 30% of the difference in health status between Europe and the U.S. We estimate a one percentage point negative impact on the life-time cost-of-living of Americans from higher prices due to inefficiencies.
Subjects: 
Health production
health status
heterogeneous agent model
price indices
JEL: 
C51
D61
E21
I10
I32
Document Type: 
Working Paper

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.